Javier García‐Frade

Author

Javier García‐Frade

Also Known As

Ana María Rodríguez-Huerta, J. Garcia-Frade, J. García-Frade, J. J. Sánchez-Blanco, Javier Garcia-Frade, Javier Garcia‐Frade, Javier García-Frade, Javier García-Frade, Javier García‐Frade

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Río Hortega Hospital Universitario 12 De Octubre Hospital General Universitario Gregorio Marañón Hospital Universitario Central de Asturias Hospital Clínico San Carlos

About

Javier García‐Frade is an author at Hospital Universitario Río Hortega specializing in medicine, pathology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	354
2	Immunology	2	2	327
3	Health Sciences	1	1	148
4	Public Health	1	1	11
5	Orthopaedics	1	1	16

Javier García‐Frade

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Experimental and Clinical Regenerative Capability of Human Bone Marrow Cells After Myocardial Infarction Francisco Fernández‐Avilés, J. Alberto San Román, Javier García‐Frade, Circulation Research	2004	469
Influence of Pre- and Post-Transplantation Responses on Outcome of Patients With Multiple Myeloma: Sequential Improvement of Response and Achievement of Complete Response Are Associated With Longer Survival Juan José Lahuerta, María‐Victoria Mateos, Joaquín Martínez‐López, Journal of Clinical Oncology	2008	280
A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma Laura Rosiñol, Josè Antonio Pérez-Simón, Anna Sureda, Blood	2008	264
Immunophenotypic analysis of Waldenstrom's macroglobulinemia Jesús F. San Miguel, María‐Belén Vídriales, Enrique M. Ocio, Seminars in Oncology Autoimmune DiseaseHistopathologyImmunologyPathologyImmunophenotyping	2003	179
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia Tomás José González‐López, Cristina Pascual, María Román, American Journal of Hematology ImmunohematologyImmunodeficienciesImmunologyPathologyPharmacotherapy	2014	148
Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study Juan José Lahuerta, M.V. Mateos, Joaquín Martínez‐López, Haematologica	2010	111
Use of eltrombopag after romiplostim in primary immune thrombocytopenia José Ramón González‐Porras, María Eva Mingot‐Castellano, Marcio Andrade, British Journal of Haematology	2014	77
Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients Nina Borràs, Javier Batlle, Almudena Pérez‐Rodríguez, Haematologica	2017	54
Use of eltrombopag for secondary immune thrombocytopenia in clinical practice Tomás José González‐López, María Román, Cristina Pascual, British Journal of Haematology	2017	35
Successful Discontinuation of Eltrombopag after Complete Remission in Patients with Primary Immune Thrombocytopenia Tomás José González‐López, Cristina Pascual, María Román, Blood	2014	28

Page 1